interferon alfa (Ascendis Pharma)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterferon alfa (Ascendis Pharma)
Drug Alias NameTransCon PEG interferon alphainterferon alpha (Ascendis Pharma)ACP-007
ClassificationBiologics
Mechanisms of ActionInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAscendis Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAscendis Pharma A/S
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A